ND	Neurodegenerative disease
AD	Alzheimer’s disease
APP	Amyloid precursor protein
Aβ	Amyloid beta peptide
HCHWA-D	Hereditary cerebral hemorrhage with amyloidosis
PiD	Pick’s disease
GFAP	Glial fibrillary acidic protein
SPECT	Single-photon emission computed tomography
PET	Positron emission tomography
APOE	Apolipoprotein E
BBB	Brain Blood Barrier
HDL	High density lipoprotein
CNS	Central Nervous System
NFTs	Neurofibrillary Tangles
GWAS	Genome-wide association study
PP2A	Protein phosphatase 2A
FTD	Frontotemporal Dementia
CTD	Chronic traumatic encephalopathy
CBD	Corticobasal degeneration
DAM	Disease-associated microglia
MGnD	Microglial neurodegenerative
TREM2	Triggering receptor expressed on myeloid cells 2
CRP	C-reactive protein
MCI	Mild cognitive impairment
MAPT	Microtubule-associated protein tau
PSP	Progressive supranuclear palsy
PHF	Abnormally hyperphosphorylated taus
CL	Centiloids
SUVR	Standardized Uptake Ration
PD	Parkinson’s disease
SNpc	Substantia nigra pars compacta
DA	Dopamine
DMV	Dorsal motor nucleus of vagus
OB	Olfactory bulb
LC	Locus coeruleus
IML	Intermediolateral nucleus in spinal cord
ENS	Enteric nervous system
EOPD	Early-onset Parkinson’s disease
mitoQC	Mitochondrial quality control
DFO	Deferrioxamine
DFP	Deferiprone
HD	Huntington’s disease
MSNs	Medium spiny neurons
mHTT	Mutation of the huntingtin gene
HTT	Huntingtin gene
CBP	cAMP response element-binding protein
MSK1	Mitogen-activated and stress-activated protein kinase 1
PGC-1a	Proliferator-activated receptor gamma coactivator alpha
HDAC	Histone deacetylase
BDNF	Brain-derived neurotrophic factor
ASOs	Antisense oligonucleotides
RNAi	RNA interference
CoQ10	Coenzyme Q10
CREST-E	Creatine safety tolerability efficacy in Huntington’s disease
ALS	Amyotrophic lateral sclerosis
FALS	Familial amyotrophic lateral sclerosis
DPR	Dipeptide repeat proteins
FUS	Fused in Sarcoma
miRNA	Micro RNA
PTM	Post-translational modification
UMN	Upper motor neuron
LMN	Lower motor neuron
PMA	Progressive muscular atrophy
PBP	Pseudobulbar Palsy